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Chronic Rhinosinusitis with or without Nasal Polyps (CRSwNP and CRSsNP) may be characterized
by different cytokine profiles. Generally, Th2 cytokines and eosinophilic infiltration have been reported
to be more specific of CRSwNP compared to CRSsNP, where neutrophils seem to playa major role. The
epithelial cell-derived thymic stromallymphopoietin (TSLP) has been recently identified as a key factor
in Th2-inflammatory response. The aim of this study is to investigate the expression of TSLP Receptor
(TSLP R) in surgical specimens obtained from patients affected by CRSwNP (n=10) and CRSsNP (n =
5) by immunohistochemical techniques (immunostaining score, IS). TSLP R expression was significantly
higher in the inflammatory infiltrate and in the epithelial cells of CRSwNP, CRSsNP patients compared
to the control group (IS 4.5±0.68, 4.4±1.44 and 0.43±0.3 respectively, p=0.0024 for inflammatory infiltrate
and IS 5.8±0.92, 7.8±2.06 and 0.86±0.55 respectively, p=0.0018 for epithelial cells). No significant
difference was observed in IS of inflammatory infiltrate and epithelial cells in CRSwNP compared to
CRSsNP. Very low IS for TSLP R was found in connective tissue of all the samples, with no difference
among the groups. TSLP receptor is highly expressed in CRS compared to controls and independently
from the polyps suggesting an early common inflammatory pathway in the two CRS phenotypes.
Chronic rhinosinusitis is a significant and
increasing health problem with a prevalence of
10.9% in the European countries. It is a disease that
can significantly affect health-related quality of life
and daily functioning, representing a huge financial
burden to society and healthcare systems as a result
of the direct and indirect costs (1-2). The relative
roles of initiating events, environmental factors, and
host susceptibility factors are all currently unknown
(3). Chronic rhinosinusitis (CRS) is a multifactorial
disease: contributing factors can be mucociliary
impairment, bacterial infection, allergy, swelling
of the mucosa for other reasons or, rarely, physical
obstruction caused by anatomical variations in the
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nasal cavities or paranasal sinuses.
The reason why polyps develop in some patients
and not in others remains unknown; nasal polyps
consist ofconnective tissue, edema and inflammatory
cells such as eosinophils (the most common),
neutrophils, mast cells, plasma cells, lymphocytes
and monocytes. Nasal polyps have a strong tendency
to relapse after functional endoscopic sinus surgery
(FESS), suggesting different pathogenic mechanisms
underlying CRS with and without nasal polyps
(CRSwNP and CRSsNP) (4-5). Actually nasal
polyps have been associated with IL5, local nasal
IgE production, eosinophils, eotaxin, and eosinophil
cationic protein (ECP) (Th2 driven disease), whereas
in CRSsNP a less defined Th2 profile, neutrophil
infiltration, INFy and TGFp production have been
reported (6-7).
The epithelial cell-derived thymic stromal
Iymphopoietin (TSLP) has been recently identified
as a key factor in Th2-inflammatory response:
it is a cytokine which is mainly expressed by
epithelial cells in the thymus, lung, skin, intestine
and tonsils. Its expression may be induced by
different exogenous/endogenous stimuli, as well as
pathogens, traumas, infections, allergens, Toll Like
Receptor Ligands (TLR-ligands), pro-inflammatory
and Th2 cytokines (8).
TSLP receptor (TSLP R) is expressed on several
immune cel1s, such as dendritic cells (DCs), B
cells, T cells, mast cells, natural killer-T (NK-T)
and monocytes, and on many organ tissues such as
heart, skeletal muscle, kidney and liver. The receptor
is a heterodimeric complex made up of two chains,
TSLP Rand IL7Ra and its phosphorilation activates
STAT5 pathway (8).
TSLP endows DCs to induce the differentiation of
inflammatory Th2 cells up-regulating co-stimulatory
molecules (CD40, CD80), MHC II molecules and
OX40 ligand (OX40L) (8-10). A pathogenetic role
of TSLP in some Th2 driven diseases like asthma
(11-12) and atopic dermatitis (AD) (13-16) have
been recently suggested.
Our hypothesis is that TSLP may play an
important role also in CRS pathogenesis, where
epithelial barrier of sinus mucosal surface may
initiate inflammatory response by secreting various
cytokines and chemokines, which regulate innate
immune cells.
Increased levels of TSLP in nasal mucosa of
patients affected by allergic rhinitis have been
reported by Mou (17-18) and, in a recent study, Liu
et al. showed high levels ofTSLP in nasal epithelial
layer ofpatients with nasal polyps (19).
In the present study we wanted to investigate
whether the expression of TSLP receptor was
increased in patients with CRS compared to controls
and whether there was a difference in TSLP R
expression in CRSwNP compared to CRSsNP. To
this end, the expression of TSLP R was analyzed
by immunohystochemical technique on surgical
specimens of sinus biopsies obtained from patients
affected by CRSwNP and CRSsNP and from controls
(subjects who underwent cosmetic rhinoplasty).
MATERIALS AND METHODS
Patients
Between January and July 20 I0 at the First ENT
Division of the University of Turin-Italy, 15 consecutive
Caucasian patients (10 male: 67%; and 5 female: 33%)
with a mean age of 51.46±13 years (range 34-78 years)
affected by chronic rhino-sinusitis (CRS) with and
without nasal polyps were enrolled in this prospective
study which was approved by the local research
committee (Table I). Each patient gave written informed
consent. Exclusion criteria were: odontogenic CRS and
nasal polyps with clinical aspects of inverted papilloma.
Diagnosis of CRSwNP and CRSsNP was made by ENT
anamnesis, ENT physical and fibre optical examination
and by sinuses CT scan, according to European Position
Paper on Rhinosinusitis 2007 criteria (Table II). The
allergic status of all patients was investigated by means of
cutaneous prick and patch tests.
Each patient was firstly treated with at least one
cycle of oral antibiotics (penicillin/cephalosporin/
fluoroquinolones), oral steroids (metilprednisone)
associated with intranasal corticosteroids (mometasone
furoate, fluticasone furoate, budesonide) and nasal
washing. After treatment failure all the patients were
recruited for surgical intervention. No patients had been
surgically treated previously.
Surgical treatment consisted in functional endoscopic
sinus surgery (FESS), in order to erase the polyps and to
clear all the involved paranasal sinuses. The procedural
technique was that described by Graz School (20). Biopsy
specimens were collected from ostio-meatal complex
mucosa in patients affected by CRSsNP, from nasal polyp
in patients with CRSwNP and from nasal respiratory
mucosa of the control group (subjects who had undergone
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cosmetic rhinoplasty or who had uncorrelated pathologies,
obtained from the Pathological Anatomy Division of the
University of Turin); all specimens were immediately
placed in a 10% buffered formalin solution, routinely
processed, and embedded in paraffin; 4-~m-thick
consecutive sections were cut for the study.
Immunohistochemistry
Samples were deparaffinized in xylene and rehydrated
in a series of graded alcohols. The sections were treated
with a 3% solution of HP2 for 30 minutes to inhibit
endogenous peroxidase activity. Non specific binding
sites were blocked by pre-incubation with fetal bovine
serum for 25 minutes at room temperature. Reacted tissue
sections were then incubated with I00 ~I of polyclonal
goat anti-human TSLP R (R&D System, Abingdon, UK;
dilution I:6,6) for 1.5 h at room temperature.
The primary antibody was replaced by fetal bovine
serum in negative controls, whereas normal human liver
specimens were used as positive controls.
Biotinylated rabbit-antigoat IgG (H+L) was obtained
from Sigma (Sigma Pharmaceutical Ltd., South Croydon,
Australia), and the avidin-biotin peroxidase complex kit
was from DAKO LSAB (Dako, Carpinteria, Calif). The
sections were then treated for 30 min at room temperature
with biotinylated rabbit-antigoat immunoglobulin
(dilution I:2000), followed by incubation with avidin-
biotin peroxidase complex solution for 15 min and
diaminobenzidine tetrahydrochloride as chromogen.
The slides were finally counterstained with Mayer's
hematoxylin for 5 seconds, dehydrated, and mounted in
Clarion (Biomeda, Foster City, California).
Table I. Patients' characteristics and surgical procedure.
Healthy nasal mucosa samples were used as control
group and analysed as described for the CRS specimens.
Interpretation ofimmunohistochemical stains
TSLP R expression was interpreted semi-quantitatively
evaluating the specimens at three different levels: the
inflammatory infiltrates, the respiratory epithelium and the
stromal/fibroblastic component (connective tissue), using
a grade for each level: grade 0 (1-10% of positive cells),
grade I (11-25% of positive cells), grade 2 (26-50% of
positive cells), grade 3 (51-75% of positive cells), grade
4 (76-100% of positive cells). After detecting the intensity
of the inflammatory infiltrates, the staining intensity for
the three cell types was scored as 0 (negative), I (weak),
2 (medium), and 3 (strong). The immunoreactivity score
was determined by multiplying staining intensity score
by grade score (intensity x grade score: maximum
immunostaining score (IS) 12).
Statistical analyses
All statistical analyses were carried out using
GraphPad Prism 4. For normal distribution data, one-
way ANOYA was used for determining the statistical
significance of differences in TSLP R expression in
the inflammatory infiltrates and respiratory epithelial
cells among CRSwNP, CRSsNP and the control group
(probability value of p<0.05 was considered statistically
significant). For non-normal distribution, one-way
ANOYA with Kruskal-Wallis test was performed.
Furthermore, multiple comparison analysis was always
performed by the Student's r-test adopting the Bonferroni
method to have a stricter criterion on whether to accept an
Number of patients (%)
Inhalants Allergy 8 (53)
Allergic Asthma 6 (40)
Clinical Diagnosis
CRSwNP 10(67)
CRSsNP 5 (33)
Paranasal sinuses involvement
Ethmoidal CRS 3 (23)
Maxillary CRS I (7)
Ethmoidal-maxillary CRS II (70)
Histological diagnosis
Inflammatory polyps 10 (67)
Chronic mucosal inflammation 5 (33)
Surgical procedure (FESS)
Polipectomy 10 (67)
Middle Antrostomy 12 (80)
Ethmoidectomy 14(93)
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Table II. Adaptedfrom EPOS 2007: recommendationsfor the diagnosis ofCRS.
Subjective assessment of rhinosinusitis: symptoms (duration of symptoms> 12 weeks without their complete
resolution)
·
Nasal blockage, congestion or stuffiness;
·
Nasal discharge or postnasal drip, often mucopurulent;
·
Facial pain or pressure, headache, and
·
Reduction/loss of smell.
Physical examination
·
Anterior rhinoscopy
·
Endoscopy
·
Imaging (facial bones CT scan)
Fig. 1. TSLP R immunostaining. Nasal mucosa from healthy subjects (A-B): negative staining in epithelial and
irfiammatory cells; nasal mucosa from CRSsNP subjects (C-D): intense staining density interesting the epithelial layer
and the inflammatory infiltrate, black arrows indicate the massive epithelial cells staining and the intlammatory cells
staining: (original magnification x200).
effect as significant (p<O.OI6).
RESULTS
In sinus bioptic samples of CRS patients
eosinophilic infiltration with scattered mast cells
and histiocytes was present, compared to a few
lymphocytes in healthy controls.
TSLP R expression was evaluated separately in
inflammatory infiltrate, respiratory epithelium, and
connective tissue (stromal cells and fibroblasts).
In CRS, TSLP R expression appeared generally as
- ...
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Fig. 2. TSLP R immunostaining. Nasal polyps from CRSwNP subjects: intense staining grade in epithelial cells (black
arrows in panel A) and in the inflammatory infiltrate (black arrow in panel B), (original magnification x200); inflammatory
infiltrate ofnasal polyps from CRSwNP subjects (C-D): black arrows show the Golgian dot like positivity in inflammatory
cells (original magnification x400).
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Fig. 3. Single and mean values of TSLP R percentage ofpositive cells in (A) inflammatory infiltrates. (B) epithelial
cells.
apical granular cytoplasmic staining in epithelial cells
and as widespread granular cytoplasmic staining in
inflammatory cells underlying respiratory epithelium
(Fig. 1). In a few pathological specimens, a Golgian
dot like staining was observed in inflammatory cells
(Fig. 2).
An increased percentage of TSLP R positive
cells was observed in inflammatory and epithelial
cells of CRSwNP and CRSsNP compared to control
group (54.5±5.9%, 38.4±8.1% and 5.3±3.8%, p<
0.0001 positive inflammatory cells and 66.1±6.6%,
66±12.4%, 7.7±4.3%, p< 0.0001 positive epithelial
cells respectively). No significant difference was
observed between CRSwNP and CRSsNP in either
inflammatory or epithelial cells (Fig. 3).
Immunostaining score (IS) (staining intensity x
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Fig. 4. Single and mean values of TSLP R immunostaining scor~ in (A) inflammatory infiltrates. (B) epithelial cells and
(C) stromallfibroblastic component.
grade score, see Methods) of inflammatory infiltrate
was significantly higher in CRSwNP and CRSsNP
compared to the control group (4.5±0.68, 4.4± 1.44
and 0.43±0.3 respectively, p= 0.0024), with no
significant difference between CRS subtypes. IS
of epithelial cells also was significantly higher in
CRSwNP and CRSsNP compared to the control group
(5.8±0.92, 7.8±2.06 and 0.86±0.55 respectively, p=
0.00 18) with no significant difference between CRS
subtypes (Fig. 4, panel A and B).
TSLP R expression could not be appreciated
at all, or the staining intensity was very low in the
connective tissue of all the groups (Fig. 4, panel C).
DISCUSSION
Our results show that TSLP R is barely expressed
in normal sinus tissue, whereas it is highly expressed
in CRS, both in inflammatory and epithelial cells,
with no significant difference between CRS subtypes
(CRSwNP and CRSsNP). The cells with the highest
TSLP R immunostaining score were eosinophils,
mast cells and histiocytes in accordance with the
data reported by Allakhverdi and coIl. who showed
that eosinophiIs and mast cells express the functional
TSLP R complex and are able to respond to TSLP
signals in the presence of inflammatory environment
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in a dose-dependent manner (21-23). We did not
observe any TSLP receptor immunostaining in the
connective tissue either in CRS or in healthy controls.
Our results suggest a leading role of epithelial cells
in addressing inflammatory response towards a
Th2 pattern, as supported by the highest TSLP R
expression observed in eosinophils and mast cells.
We found that TSLP R was equally highly
expressed in CRSwNP and CRSsNP, suggesting
a common pathway in the inflammatory response
which starts from the epithelial barrier and through
TSLP-TSLP R interaction drives the nasal mucosa
through a Th2-inflammatory response. In our series
we could not note any difference in the inflammatory
infiltrate, which was mainly eosinophilic, either
in CRSwNP or in CRSsNP. The pathogenetic
mechanisms, which lead to the development of
nasal polyps, are still unknown and probably involve
different cytokines, like TNFa or ILl p, and growth
factors. Transforming growth factor-beta (TGFP) has
been implicated as an important factor in remodeling
processes involved in chronic sinus disease, and
plays as a main switch for different remodeling
patterns in chronic sinus disease (24).
To our knowledge, no previous report has
investigated the TSLP R expression in CRS patients
with or without nasal polyps.
In conclusion, this study suggests a critical role
for TSLP as a driving factor in the pathogenesis
of CRS, supported by the massive presence of its
receptor both in the inflammatory cells and epithelial
layer. The emerging concept oftissue-specific control
of immunity, with TSLP secretion at the epithelial
level acting as an initial factor in the CRS cascade,
can partially explain the early stages of the disease.
Further studies on the immune mechanisms involved
in nasal polyps formation are required.
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